Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge” or the “Company”)...
-
Block & Leviton is investigating BioAge Labs after the company discontinued its STRIDES Phase 2 trial for azelaprag. Investors should contact the firm.
-
Block & Leviton is investigating BioAge Labs, Inc. (Nasdaq: BIOA) for potential securities law violations. Investors should contact the firm to learn more.